Cannabidiol (CBD) is quite popular and there are many CBD products out there. However, there is a lot of exaggerated information about CBD. This has led people to believe that it can heal. The U.S. Food and Drug Administration has been educating the public on cannabis (CBD) products. The FDA campaign has been ongoing for over a year. Health authorities are focused on providing information on the risks, potential uses, and the real science behind how CBD works in the body. The FDA has also been working on addressing products that violate the law.
New CBD products hit the market every other day. This includes teas, cosmetics, chocolate bars, lotions, oils, capsules, and more. Some of these products are for humans while others are designed for our pets. According to the FDA, a large number of CBD products on the market have not been approved. Authorities understand that the availability of these products may create the impression that they have been evaluated and approved.
According to the FDA, you should be careful of CBD products that claim to treat health conditions. To date, U.S. health authorities have only approved one drug made from CBD. This drug, Epidiolex, is meant for the treatment of two rare and severe epilepsy that affect children.
Health officials say the public must be aware that CBD can have harmful side-effects on the body. Unregulated CBD products can result in liver injury and have interactions with other drugs. Some low-quality CBD products can also negatively affect the male reproductive system and cause drowsiness.
Officials in the FDA have cautioned the public to be careful with ingesting CBD products since studies into their long-term effects are still unknown. This does not mean that CBD is not safe. However, there are many ongoing studies into this cannabinoid to improve our understanding of it. The FDA reports that children, elderly people, pregnant, and lactating women may be at risk when using CBD products. The FDA strongly advises that people consult with their doctors before using just any CBD products.
The FDA is looking to develop data to close the knowledge gap between what is known about the safety of CBD and the potential benefits of CBD products. The health agency is looking to " further evaluate any potential benefits outside of the one FDA-approved drug product to treat two rare, severe pediatric epilepsy disorders."
"This includes data on, among other things: the sedative effects of CBD; the impacts of long-term sustained or cumulative exposure to CBD; transdermal penetration and pharmacokinetics of CBD; the effect of different routes of CBD administration (e.g., oral, topical, inhaled) on its safety profile; the safety of CBD for use in pets and food-producing animals; and the processes by which “full-spectrum” and “broad spectrum” hemp extracts are derived, what the content of such extracts is, and how these products may compare to CBD isolate products."CBD products are not intended to diagnose, treat, cure or prevent any disease. All the information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.
Comments will be approved before showing up.